Jinyu Bio-technology Co., Ltd. (SHA:600201)

Market Cap	8.59B
Revenue (ttm)	1.26B
Net Income (ttm)	79.88M
Shares Out	1.12B
EPS (ttm)	0.07
PE Ratio	105.80
Forward PE	41.66
Dividend	0.03 (0.40%)
Ex-Dividend Date	Jul 15, 2024

Volume	19,340,735
Average Volume	19,544,416
Open	7.69
Previous Close	7.69
Day's Range	7.62 - 7.86
52-Week Range	5.62 - 8.14
Beta	0.65
RSI	69.61
Earnings Date	Aug 24, 2025

About Jinyu Bio-technology

Jinyu Bio-technology Co., Ltd. engages in the research and development, production, and sale of veterinary products in China. Its product portfolio includes Jinyu Baoling, Yangzhou Youbang, and Liaoning Yikang animal vaccines for the prevention of foot, porcine, mycoplasma pneumoniae, porcine reproductive and respiratory syndrome, porcine pseudorabies, pathogenic avian influenza, brucellosis bacterial disease, bovine viral diarrhea and mucosal, infectious rhinotracheitis, and other domestic animal diseases. The company was founded in 1992 and i...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1992
• Employees: 1,740
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600201

Financial Performance

In 2024, Jinyu Bio-technology's revenue was 1.26 billion, a decrease of -21.45% compared to the previous year's 1.60 billion. Earnings were 108.99 million, a decrease of -61.57%.